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Abstract
Programmatic surveillance of intestinal schistosomiasis during control can typically use four
diagnostic tests, either singularly or in combination, but these have yet to be cross-compared
directly. Our study assembled a complete diagnostic dataset, inclusive of infection intensities,
from 258 children from five Ugandan primary schools. The schools were purposely selected as
typical of the endemic landscape near Lake Albert and reflective of high- and low-transmis-
sion settings. Overall prevalence was: 44.1% (95% CI 38.0–50.2) by microscopy of duplicate
Kato-Katz smears from two consecutive stools, 56.9% (95% CI 50.8–63.0) by urine-circulating
cathodic antigen (CCA) dipstick, 67.4% (95% CI 61.6–73.1) by DNA-TaqMan® and 75.1%
(95% CI 69.8–80.4) by soluble egg antigen enzyme-linked immunosorbent assay (SEA-
ELISA). A cross-comparison of diagnostic sensitivities, specificities, positive and negative pre-
dictive values was undertaken, inclusive of a latent class analysis (LCA) with a LCA-model
estimate of prevalence by each school. The latter ranged from 9.6% to 100.0%, and prevalence
by school for each diagnostic test followed a static ascending order or monotonic series of
Kato-Katz, urine-CCA dipstick, DNA-TaqMan® and SEA-ELISA. We confirm that Kato-
Katz remains a satisfactory diagnostic standalone in high-transmission settings but in low-
transmission settings should be augmented or replaced by urine-CCA dipsticks. DNA-
TaqMan® appears suitable in both endemic settings though is only implementable if resources
permit. In low-transmission settings, SEA-ELISA remains the method of choice to evidence
an absence infection. We discuss the pros and cons of each method concluding that future
surveillance of intestinal schistosomiasis would benefit from a flexible, context-specific
approach both in choice and application of each diagnostic method, rather than a single
one-size fits all approach.
Introduction
Developing appropriate diagnostics tools, methods and protocols to track parasitic diseases
before, during and after control is an important component within the multi-disciplinarity
of parasitology. It has been previously highlighted (Stothard and Adams, 2014) and with
regard to schistosomiasis, intestinal schistosomiasis poses a considerable public health burden
in Uganda (Loewenberg, 2014). Since 2003 there has been an active national control pro-
gramme against it (Kabatereine et al. 2006, 2007; Fenwick et al. 2009; Stanton et al. 2017),
as primarily based on preventive chemotherapy campaigns (Montresor et al. 2012; Stothard
et al. 2013). Despite much progress in the delivery of praziquantel (PZQ) treatments to school-
aged children, infections with Schistosoma mansoni continue to be pervasive, particularly
along the immediate shoreline of Lake Albert (Al-Shehri et al. 2016). Moving some 10–
20 km inland, however, infection prevalence by school can decline dramatically, at least if mea-
sured by faecal egg-patency for if more sensitive diagnostic tools were used, such as
urine-antigen dipsticks, such declines are less precipitous (Stothard et al. 2006, 2017b).
The incongruence between ‘estimated’ and ‘true’ prevalence is a well-known diagnostic
dilemma in surveillance of intestinal schistosomiasis largely due to an operational compromise
between imperfect detection tools and insufficient specimen sampling (Bergquist et al. 2009,
2015; Stothard et al. 2014; Utzinger et al. 2015; Weerakoon et al. 2015). Nonetheless, if control
programmes are to be monitored effectively and also permit evidence-based adaptation or
revision of control tactics (Tchuente et al. 2017), infection dynamics at an individual level
need to be captured alongside any broader changes in the epidemiological landscape amenable
to measurement (Hawkins et al. 2016; Stothard et al. 2017a). As the strive towards elimination
grows (Hawkins et al. 2016; Colley et al. 2017), previous diagnostic shortcomings are revealed
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S003118201800029X
Downloaded from https://www.cambridge.org/core. Liverpool School Of Tropical Medicine, on 22 Mar 2018 at 11:27:02, subject to the Cambridge Core terms of use, available at
highlighting new diagnostic needs that guide future target product
profiles (Utzinger et al. 2015; Weerakoon et al. 2015; Hawkins
et al. 2016; Savioli et al. 2017; Tchuente et al. 2017).
At an individual level, often the school-aged child, the diag-
nostic repertoire for surveillance of intestinal schistosomiasis
within national control programmes has remained surprisingly
meagre; for many years it has been exclusively founded on para-
sitological methods alone (Stothard et al. 2014), with only spor-
adic application of serological methods (Chernet et al. 2017;
Hinz et al. 2017). With the growing need for modernization
and interest in adoption of more sensitive disease diagnostics in
general (Mabey et al. 2004; Solomon et al. 2012; Stothard and
Adams, 2014), in recent years there have been two important
developments that centre upon scale-up in the use of urine-
circulating cathodic antigen (CCA) dipsticks (Colley et al. 2013;
Sousa-Figueiredo et al. 2013; Foo et al. 2015; Danso-Appiah
et al. 2016; Greter et al. 2016; Kittur et al. 2016) and development
of DNA-detection platforms with real-time PCR with parasite-
specific TaqMan® hydrolysis probes (ten Hove et al. 2008; Mejia
et al. 2013; Easton et al. 2016). Furthermore, recent application
of more sophisticated statistical modelling such as latent class
analysis (LCA) (Hadgu et al. 2005), has advanced diagnostic
tool performance comparisons beyond the direct need of a fixed
reference ‘gold’ standard which, for schistosomiasis, is something
we currently do not have (Shane et al. 2011; Ibironke et al. 2012;
Koukounari et al. 2013; Beltrame et al. 2017).
In this study, we attempt to make a diagnostic comparison for
surveillance of intestinal schistosomiasis in school children across
five primary schools using four methods namely: microscopy of
duplicate Kato-Katz smears from two consecutive stools,
urine-CCA dipsticks, real-time PCR of stool with a
Schistosoma-specific Taqman® probe and serological analysis of
finger-prick blood for antibodies against schistosome soluble
egg antigen (SEA). Diagnostic congruence was first assessed by
empirical cross-tabulations, assuming a ‘gold standard’, then
later by LCA with disease prevalence by school also estimated
with a LCA model.
Methods
Study area, participants and ethical approval
Field sampling and examinations of children took place in May
2015 in five primary schools in Buliisa District located within
the Lake Albert region, three of which have been visited previ-
ously as sentinel surveillance sites of the national control pro-
gramme (Kabatereine et al. 2007) and the global positioning
system locations (GPS) known (Fig. 1). The schools Walakuba
(GPS 01°50.323N, 031°22.740E), Bugoigo (GPS 01°54.004N,
031°24.750E) and Runga (GPS 01°43.828N, 031°18.603E) were
located on the immediate shoreline while Biiso (GPS 01°
45.516N, 031°25.236E) and Busingiro (GPS 01°44.090N, 031°
26.855E) were over 10 km away inland which aimed to represent
the current control landscape across high- and low-endemic set-
tings, respectively.
After obtaining written informed consent and verbal assent, a
pre-target of 60 children of balanced gender aged between 5 and
10 years of age were enrolled and requested to provide two stool
samples on consecutive days, a single urine sample and single
finger-prick blood sample. Children were also interviewed with
a standardized questionnaire to ascertain recent PZQ treatment
history. All participants were provided with a single PZQ
(40 mg/kg) treatment by the attending nurse following WHO
guidelines (Montresor et al. 1998). The Ugandan Council for
Science and Technology and the Liverpool School of Tropical
Medicine granted approval for this study.
Diagnostics: faecal microscopy with Kato-Katz
Duplicate Kato-Katz thick smear slides (41.7 mg templates) were
prepared from each stool received after first sieving through a
212 µM metal mesh (Montresor et al. 1998). Schistosome eggs
were viewed by microscopy (×100 magnification), quantified
and expressed as eggs per gram (EPG) of faeces with the intensity
of infection classified as: light (1–99 EPG), medium (100–399
EPG) and heavy (⩾400 EPG) following the WHO guidelines
(Montresor et al. 1998). For later DNA analysis, a 0.8 g aliquot
of sieved stool was each prepared and stored in 95% ethanol
before transportation to the UK for processing.
Diagnostics: schistosome urine-antigen CCA dipsticks
The commercially available urine-CCA dipstick was used to test for
schistosome antigens in each urine sample received following man-
ufacturer’s instructions (Rapid Medical Diagnostics, Pretoria,
South Africa). The test result was classified by visual inspection
against a colour chart as used previously (Sousa-Figueiredo et al.
2013), by two individuals as negative, trace (±), light positive (+),
medium positive (++) and heavy positive (+++). In this setting,
Fig. 1. (A) Schematic map of the five sampled primary schools in the Lake Albert
region, the blue area indicates Lake Albert. (B) Estimated prevalence of
Schistosoma mansoni by school for each examined diagnostic test; prevalence by
any positive test criterion is also illustrated.
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all trace reactions were later considered to be positive as justified
previously upon biological causality and by prior epidemiological
analyses (Standley et al. 2010a, b; Sousa-Figueiredo et al. 2013;
Adriko et al. 2014).
Diagnostics: schistosome serology with SEA-enzyme-linked
immunosorbent assay (ELISA)
Finger-prick blood was taken from each child and antibodies for
SEA were tested using 1 : 40 dilution of harvested sera using a
field-based ELISA test following manufacturer’s instructions
(IVD Inc.; Carlsbad, USA). Upon completion, the micro-titre
plate was placed on a white card to view the visual colour of
each reaction as graded into pale yellow (light positive), yellow
(medium positive) and dark yellow (heavy positive) as recorded
previously (Stothard et al. 2009).
DNA diagnostics: TaqMan® real-time PCR
After transfer to the UK, each aliquot of stool was spiked with
Phocine Herpes Virus (PhHV-1) to act as an internal control
for each DNA extraction and later real-time PCR assay for inhib-
ition following protocols of Meurs et al. (2015) which targetted a
77 base pair segment within the ribosomal internal transcribed
spacer (ITS-2) region which can be identified using S. mansoni
(GenBank: AF503487) as reference sequence (Obeng et al. 2008;
Meurs et al. 2015). Schistosome DNA was detected with the
Schistosoma-specific primers of Ssp48F (GGT CTA GAT GAC
TTG ATY GAG ATG CT) and Ssp124R (TCC CGA GCG YGT
ATA ATG TCA TTA) and TaqMan® probe Ssp78T (ROX –
TGG GTT GTG CTC GAG TCG TGGC – Black Hole
Quencher 3) as developed by (Obeng et al. 2008; Meurs et al.
2015). DNA-TaqMan® assays were performed in a Chromo-4
with Opticon monitor Version 3.1. (Biorad, Hemel Hempstead,
UK) with Biorad iQ™ supermix and thermal cycling conditions
of 15 min at 95 °C, followed by 45 cycles, each of 15 s at 95 °C
and 60 s at 60 °C. The infection intensity was classified according
to Ct values: negative (Ct > 45), light positive (35 > Ct⩽ 45),
medium positive (25 > Ct⩽ 35), and heavy positive (Ct ⩽ 25).
Data management and statistical analysis
All data collected in the field and processed in the laboratory were
recorded on proforma data sheets. These were then double
entered in Microsoft Excel prior to the generation of summary
tables for prevalence and intensity of infection (Tables 1 and 2).
Empirical estimates of sensitivity, specificity, negative predictive
value and positive predictive value was calculated in R statistical
package v 2·10·1 (The R Foundation for Statistical Computing,
Vienna, Austria) and SPSS software (v 24.0, SPSS Inc., IBM,
USA) assuming the urine-CCA as the ‘gold’ standard against
the remaining three diagnostic tests (Table 3). For percentage
values, 95% confidence intervals (95% CI) were estimated using
the exact method (Armitage and Berry, 1994). We have decided
to assume the urine-CCA as the gold standard for our descriptive
analyses (i.e. empirical estimates of diagnostic performance), since
there have been extensive evaluations of urine-CCA dipsticks
(Colley et al. 2013) and WHO recommendation of its use in sur-
veillance mapping (Danso-Appiah et al. 2016).
Subsequently, to tackle the inherent problems with diagnostic
measurement error, we employed a LCA and full information
maximum likelihood estimation (Table 4). LCA allows grouping
of categorical data (in the current study not infected and infected
from the diagnostic tests under examination) into latent classes
indicating S. mansoni infection via a probability model. Given
the well-known epidemiological landscape of Lake Albert region,
such a model was designed to allow LCA estimated prevalence of
S. mansoni to vary by school (Table 4). Through this approach,
model-based estimates of sensitivity and specificity across diag-
nostic tests without assuming a gold standard were also obtained.
The classification certainty of this model was evaluated
through entropy; values of entropy near one indicate high cer-
tainty in classification while values near zero indicate low cer-
tainty (Celeux and Soromenho, 1996). LCA assumes the
relationships between the observed variables (i.e. diagnostic tests
in the current study) are accounted for by their class membership
and thus conditioning on class membership (i.e. the disease status
in the current study) such that if the model estimated disease sta-
tus is misclassified by one test, the probability that it will be mis-
classified by another test will not be affected. We assessed this
assumption by speculating the standardized residuals for each
response pattern from the diagnostic tests as estimated from the
LCA model. Further technical details of these models in the con-
text of schistosomiasis have been described elsewhere and thus
they are not repeated here (Ibironke et al. 2012). The LCA
model was fitted using MPlus version 7.3 (Muthén and
Muthén, 1998–2012).
Results
Prevalence of intestinal schistosomiasis
A total data set was assembled from 258 children with a preva-
lence of intestinal schistosomiasis by each diagnostic test pre-
sented, see Table 1. Overall prevalence of intestinal
schistosomiasis was: 44.1% (95% CI 38.0–50.2) by microscopy
of duplicate Kato-Katz smears from two consecutive stools,
56.9% (95% CI 50.8–63.0) by urine-CCA dipstick, 67.4% (95%
CI 61.6–73.1) by DNA-TaqMan® and 75.1% (95% CI 69.8–80.4)
by SEA-ELISA.
Table 1. Prevalence (%) of Schistosoma mansoni according to each diagnostic test across five primary schools with 95% confidence intervals
School name
Walakuba (n = 50) Runga (n = 50) Bugoigo (n = 58) Biiso (n = 50) Busingiro (n = 50) Total (N = 258)
Diagnostic method % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)
Kato-Katz 70.0 (56.8–83.1) 86.0 (76.0–95.9) 37.9 (25.0–50.8) 20.0 (8.5–31.4) 8.0 (0.2–15.7) 44.1 (38.0–50.2)
Urine-CCA dipstick 78.0 (66.1–89.8) 100 (NA) 55.1 (41.9–68.3) 38.0 (24.0–51.9) 14.0 (4.0–23.9) 56.7 (50.8–63.0)
SEA-ELISA 94.0 (87.1–100.8) 96.0 (90.3–101.6) 81.0 (70.6–91.4) 60.0 (45.9–74.0) 44.0 (29.7–58.2) 75.1 (69.8–80.4)
DNA-TaqMan 84.0 (73.4–94.5) 92.0 (84.2–99.7) 82.7 (72.7–92.7) 52.0 (37.6–66.3) 24.0 (10.1–33.8) 67.4 (61.6–73.1)
Positive by any test 98.0 (93.9–102.0) 100 (NA) 94.8 (88.9–100.0) 76.0 (63.7–88.2) 54.0 (39.6–68.3) 84.8 (80.4–89.2)
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Table 2. Intensity of infection categories for Schistosoma mansoni by each examined diagnostic test across the five primary schools
Diagnostic test and
intensity category
School name
Walakuba (n = 50) Runga (n = 50) Bugoigo (n = 58) Biiso (n = 50) Busingiro (n = 50) Total (N = 258)
(%) n (%) n (%) n (%) n (%) n N (%)
Kato-Katza
Negative 15 (30.0) 7 (14.0) 36 (60.1) 40 (80.0) 46 (92.0) 144 (55.8)
Light (<100 EPG) 5 (10.0) 7 (14.0) 16 (27.6) 3 (6.0) 1 (2.0) 32 (12.4)
Medium (100–399 EPG) 10 (20.0) 5 (10.0) 3 (5.2) 5 (10.0) 2 (4.0) 25 (9.7)
Heavy (≥400 EPG) 20 (40.0) 31 (62.0) 3 (5.2) 2 (4.0) 1 (2.0) 57 (22.1)
Urine-CCA
Negative 11 (22.0) 0 (0.0) 26 (44.8) 31 (62.0) 43 (86.0) 111 (43.0)
Light (+, incl. trace) 5 (10.0) 10 (22.0) 19 (32.8) 7 (14.0) 4 (8.0) 45 (17.4)
Medium (++) 6 (12.0) 9 (18.0) 7 (12.1) 6 (12.0) 1 (2.0) 29 (11.2)
Heavy (+++) 28 (56.0) 31 (62.0) 6 (10.3) 6 (12.0) 2 (4.0) 73 (28.3)
SEA-ELISA
Negative 3 (6.0) 2 (4.0) 11 (19.0) 20 (40.0) 28 (56.0) 64 (24.8)
Light (+, incl. trace) 4 (8.0) 3 (6.0) 14 (24.1) 16 (32.0) 13 (26.0) 50 (19.3)
Medium (++) 33 (66.0) 19 (38.0) 27 (46.5) 11 (22.0) 8 (16.0) 98 (37.9)
Heavy (+++) 10 (20.0) 26 (52.0) 6 (10.3) 3 (6.0) 1 (2.0) 46 (17.8)
DNA TaqMan®
Negative (Ct > 45) 8 (16.0) 4 (8.0) 10 (17.2) 24 (48.0) 38 (76.0) 84 (32.5)
Light (35 > Ct ⩽ 45) 4 (8.0) 2 (4.0) 20 (34.5 18 (36.0) 8 (16.0) 52 (20.1)
Medium (25 > Ct ⩽ 35) 19 (38.0) 9 (18.0) 19 (32.8) 5 (10.0) 2 (4.0) 54 (20.9)
Heavy (Ct ⩽ 25) 19 (38.0) 35 (70.0) 9 (15.5) 3 (6.0) 2 (4.0) 68 (26.3)
aDuplicate faecal smears from two consecutive stools.
Table 3. Empirical estimates of sensitivity (SS), specificity (SP), negative predictive value (NPV) and positive predictive value (PPV), Cohen’s kappa for each
diagnostic test against urine-CCA dipstick as ‘gold standard’
Evaluating
diagnostic test
Urine-CCA as reference ‘gold standard’
Cohen’s kappa
(95% Cls)
Negative
(%)
Positive
(%)
Measurement estimate
% (95% Cls)
Diagnostic accuracy
% (95% Cls)
DNA-TaqMan® Total (%)
Negative 62 (24.0) 22 (8.5) 84 (32.6) Sensitivity 85.0 (78.4–89.9) 72.5 (66.7–77.6) 0.4 (0.3–0.5)
Positive 49 (18.9) 125 (48.5) 174 (67.4) Specificity 55.9 (46.6–64.7)
Total (%) 111 (43.0) 147 (57.0) 258 (100.0) PPV 71.8 (64.7–77.9)
NPV 73.8 (63.5–82.0)
SEA-ELISA
Negative 59 (22.9) 5 (1.9) 64 (24.8) Sensitivity 96.6 (92.3–98.5) 77.9 (72.5–82.5) 0.5 (0.4–0.6)
Positive 52 (20.2) 142 (55.0) 194 (75.2) Specificity 53.2 (43.9–62.2)
Total (%) 111 (43.0) 147 (57.0) 258 (100.0) PPV 73.2 (66.6–78.9)
NPV 92.2 (82.9–96.6)
Kato-Katz
Negative 110 (42.6) 34 (13.2) 144 (55.8) Sensitivity 76.9 (69.2–82.9) 86.4 (81.7–90.1) 0.73 (0.6–0.9)
Positive 1 (0.4) 113 (43.8) 144 (44.2) Specificity 99.1 (95.1–99.8)
Total (%) 111 (43.0) 147 (56.9) 258 (100.0) PPV 99.1 (95.2–99.8)
NPV 76.4 (68.8–82.6)
4 Hajri Al-Shehri et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S003118201800029X
Downloaded from https://www.cambridge.org/core. Liverpool School Of Tropical Medicine, on 22 Mar 2018 at 11:27:02, subject to the Cambridge Core terms of use, available at
The prevalence of infection at Runga and Walakuba was
observed to be highest, exceeding 50% in all diagnostic tests,
whereas prevalence of infection at Busingiro was lowest falling
well short of 50% by any test, although pooling infection status
upon being positive by any test revealed that just under half of
the children attending this school could be considered ‘free’
from infection. For the total dataset, just over a quarter of children
(n = 69) could be considered to have no evidence of intestinal
schistosomiasis.
The geographical proximity of each of the five schools to Lake
Albert shoreline is depicted in schematic in Fig. 1A;
on-the-ground shortest distance to the lake shoreline can be
ranked in the following order of Walakuba (0.2 km), Runga
(0.4 km), Bugoigo (0.9 km), Biiso (9.4 km) and Busingiro
(13.2 km). Notably, both Runga and Bugoigo schools are located
for safety and convenience on slightly higher ground behind each
village so as not to flood, which during wetter periods has detri-
mentally affected Walakuba in the past (J.R.S., personal observa-
tion). Whilst diagnostic comparisons are made on the basis of
binary data, it is worth noting that infection intensity also varied
by school setting, in that ‘heavy intensity’ infections or ‘strong
positive’ by any test were particularly common at Runga but
were rare at Busingiro, Table 2. As shown in Fig. 1B the changing
prevalence by school for each method is clearly visible in that the
prevalence of inferred from each diagnostic test typically followed
a static ascending order or monotonic series of Kato-Katz,
urine-CCA dipstick, DNA-TaqMan® and SEA-ELISA, although
the relative position of the estimated prevalence by urine-CCA
at Runga slightly exceeds SEA-ELISA and DNA-TaqMan®.
Empirical and LCA modelling of estimates of diagnostic
performance
Assuming the urine-CCA as an arbitrary gold standard, the diag-
nostic performance for the three remaining tests is shown along
with diagnostic accuracy and Cohen’s kappa statistic, Table 3.
The sensitivity of SEA-ELISA is the highest (96.6%) but also
has the lowest specificity (53.2%), with the highest negative pre-
dictive value of all methods. By contrast, the sensitivity of
Kato-Katz is the lowest (76.9%) but also has the highest specificity
(99.1%), with the highest positive predictive value of all methods.
On the basis of LCA analysis the sensitivity and specificity of
each method can be estimated on the basis of their latent class
assignment which highlights the trade-off between diagnostic spe-
cificity (i.e. false positive) and sensitivity (i.e. false negative). In
this analysis, sensitivity and specificity of SEA-ELISA and
urine-CCA are broadly equivalent with DNA-TaqMan® appearing
to have slightly lower sensitivity and specificity. Estimating the
prevalence of infection by school with LCA, Table 4, reveals a
lower prevalence than that on the basis of positivity by any test
but follows the same static ascending order or monotonic series
(Fig. 1B). It is evident that at Runga intestinal schistosomiasis is
universal whereas at Busingiro around 9.6% of children are sus-
pected of harbouring infections.
The LCA model generated similar sensitivity for SEA-ELISA
and urine-CCA but was slightly lower for DNA-TaqMan®,
Table 4. Kato-Katz was again shown through LCA to have the
highest specificity among all the four tests. The specificity of
89.3% (95% CI 80.9–97.6) for the urine-CCA test was acceptable
but for the SEA-ELISA and the DNA-TaqMan, specificities were
less so and estimated to be 49.5% (95% CI 39.4–59.6) and 57.5%
(95% CI 48.6–66.5), trending as with empirical calculations, see
Table 3. Furthermore, LCA estimated infection prevalence of S.
mansoni by the school to be lower than that on the basis of posi-
tivity by any test (for the latter see Fig. 1B). Nevertheless, both of
these approaches suggested that intestinal schistosomiasis was
universal at Runga, however, at Busingiro LCA estimated a preva-
lence of S. mansoni infection to be 9.6% (95% CI 9.0−18.4), much
lower than that revealed by positivity upon any test. Finally, the
entropy of the LCA model was estimated to be 0.921. This indi-
cated a clear delineation of classes in the fitted model standar-
dized residuals for each response pattern from the four
diagnostic tests from this model were between −2 and 2, eviden-
cing that local independence of the four diagnostic tests is not
obviously violated.
Discussion
Owing to the complicated developmental and population biology
of the schistosome within the mammalian host, it is well known
that accurate detection of intestinal schistosomiasis by any bio-
marker can be problematic and has been the topic of at-length
discussions previously (Bergquist et al. 2009, 2015; Stothard
et al. 2014; Utzinger et al. 2015). Foremost, the insensitivity of
the Kato-Katz, especially in the detection of light egg-patent infec-
tions or in patients with a recent history of PZQ treatment, is per-
haps the most obvious obstacle to overcome (Kongs et al. 2001;
Koukounari et al. 2013; Leuenberger et al. 2016).
Indeed, how we debate and assess the significance of egg-
negative infections is changing alongside measuring morbidity
associated with intestinal schistosomiasis which goes beyond
what Kato-Katz assessments can offer (King, 2015).
Nevertheless, Kato-Katz can still be promoted as a field-applicable
standalone and appropriate in high-endemic settings, as seen here
in both Runga and Walakuba, where prevalence and intensity of
infection were high. Nonetheless, Kato-Katz has several deficits
when applied to lower transmission settings, as exemplified by
the other schools sampled here and is more misleading perhaps
than informative. To compensate, de Vlas et al. (1993) developed
a useful corrective prevalence chart which took into account
infection intensity; however, its uptake was not as good as antici-
pated (de Vlas et al. 1993). It is also outside the scope of the pre-
sent paper to discuss economic cost–benefit of faecal microscopy
(Meheus et al. 2015) other than that mobile microscopy with
handheld devices offers some attractive cost-saving solutions for
surveillance of intestinal schistosomiasis in high-endemic areas
(Stothard et al. 2005; Bogoch et al. 2014). However, as control
programmes move forward towards elimination, the Kato-Katz
methodology will be inappropriate and will be unable to provide
sufficient quality epidemiological information for precision map-
ping of disease foci (Tchuente et al. 2017). The latter is pivotal in
Table 4. Latent class analysis (LCA) estimates of sensitivity and specificity and
LCA model of prevalence of Schistosoma mansoni by school with 95% CIs for
each diagnostic method
Diagnostic method Sensitivity Specificity
Kato-Katz 84.4% (76.0–92.9) 100% (NA)
Urine-CCA 99.1% (97.3–100) 89.3% (80.9–97.6)
SEA-ELISA 97.7% (95.1–100) 49.5% (39.4–59.6)
DNA-TaqMan® 90.2% (84.2–96.2) 57.5% (48.6–66.5)
School name Prevalence by LCA model
Walakuba 75.7% (62.9–88.5)
Runga 100.0% (NA)
Bugoigo 49.7% (35.0–64.5)
Biiso 27.0% (12.2–41.9)
Busingiro 9.6% (9.0–18.4)
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the local intensification of delivery of treatments and surveillance
interventions to confirm interruption of transmission (Rollinson
et al. 2013; Stothard et al. 2017a). Indeed from the information
reported here, we would suggest that control efforts in locations
such as Busingiro should be intensified rather than reduced.
Of the remaining diagnostic methods, the diagnostic pros and
cons of each method have been discussed elsewhere often using
the ASSURED framework (Bergquist et al. 2009; Stothard et al.
2014; Utzinger et al. 2015). DNA-TaqMan® methods are, however,
increasingly gaining favour and offer a multiplex DNA-platform
for co-detection of several neglected tropical diseases as well as
many other infectious agents (Verweij and Stensvold, 2014);
much more so than other any other current biomarker method
can provide (ten Hove et al. 2008; Solomon et al. 2012; Mejia
et al. 2013; Easton et al. 2016). There also is the suggestion that
DNA-TaqMan® could become an acceptable ‘gold’ standard
(Meurs et al. 2015), andwhilst we ultimately share some enthusiasm
in this there are some impediments to discuss. Foremost,
DNA-TaqMan® requires specialist equipment and is not currently
amenable to point-of-contact settings although there is growing
interest in the use of more field-friendly methods (Minetti et al.
2016), such as loop-mediated iso-thermal amplification (LAMP)
(He et al. 2016) and recombinase polymerase amplification (RPA)
(Rosser et al. 2015). Nonetheless, from our results here the
DNA-TaqMan® has been somewhat outperformed upon consider-
ation of Table 4. In our opinion, perhaps themost significant advan-
tage of DNA-based platform is that DNA-TaqMan® assays can
cross-over into environmental monitoring through detection of
environmental (e)DNA and therefore broaden the vision of schisto-
somiasis control in general potentially uniting clinical and environ-
mental surveillance (Rollinson et al. 2013; Stothard et al. 2017a).
In the absence of a ‘gold’ standard diagnostic test and com-
plexity of the changing epidemiological landscape in which tests
are being applied in Uganda (Standley et al. 2010a, b; Adriko
et al. 2014; Al-Shehri et al. 2016), our analysis presented in
Table 3 postulated that urine-CCA dipsticks could be an ‘error-
free’ standard which, in Table 4, was further explored by LCA.
Here the probabilistic statistical model applied does not assume
any ‘gold’ standard and therefore points towards the urine-CCA
as having near-optimal diagnostic scores of sensitivity (99.1%)
and specificity of (89.3%). Moreover, these scores are significantly
better than those reported previously by empirical comparisons
(Stothard et al. 2006) and illustrate how advances in statistical
modelling developed elsewhere on urine-CCA dipsticks (Knopp
et al. 2015; Koukounari et al. 2013) can provide a deeper insight
into diagnostic score evaluations over and above simple empirical
calculations (Colley et al. 2013; Danso-Appiah et al. 2016).
Nonetheless a theoretical issue of adopting LCA-models exclu-
sively is an assumption of independence of tests which, given
the biological biomarkers employed here could be somewhat con-
founded; Kato-Katz detects eggs directly, DNA-TaqMan® mea-
sures Schistosoma-DNA in stool (presumably from excreted
eggs) and SEA-ELISA detects antibodies to secreted egg-antigens,
thus these three methods are somewhat interrelated to similar bio-
markers of the egg itself although will have each have differing
physical, biochemical and physiological components. However,
the urine-CCA dipstick is less directly connected to egg-
biomarkers for it utilizes carbohydrate-antigens released from
feeding worms of either sex and hence offers an alternative bio-
marker appraisal. Since violations of the conditional independ-
ence assumption can lead to biased LCA estimates of accuracy
and prevalence, performing and reporting checks of whether
assumptions are met is essential which was why we compared
LCA estimates of diagnostic performance with empirical ones,
drawing conclusions for each of the diagnostic tests used. In add-
ition, speculation of standardized residuals from the LCA model
indicated that the assumption of local independence of the four
diagnostic tests under examination was not obviously violated.
Over and above the routine diagnostic scores of sensitivity,
specificity, negative and positive predictive values with or without
LCA models, however, it is also necessary to further consider each
diagnostic tool against the ASSURED criteria. This seeks to
understand whether a diagnostic test can be used at scale and is
ultimately useful in several clinical and epidemiological surveil-
lance settings (Mabey et al. 2004; Peeling et al. 2006; Stothard
and Adams, 2014). The roll-out of the urine-CCA test has been
discussed previously (Stothard, 2009) and it is pleasing to see it
become further endorsed at the policy level (Danso-Appiah
et al. 2016). The most desirable features of this test are its afford-
ability, stable commercial production, the use of urine-sampling,
the speed of test and a short time to obtain results which has a
very pragmatic consideration for the end-user in this emphasis.
All of the above potentially make dissemination of epidemio-
logical results back to the local community obtained by the
urine-CCA dipstick much quicker, which is vital to increase
local ownership of preventive chemotherapy campaigns in future
(Tchuente et al. 2017).
Concluding remarks
The study has shown that intestinal schistosomiasis continues to be
a public health challenge on the shoreline of Lake Albert which now
presents as a heterogenous epidemiological landscape of high- and
low-transmission settings. A total of four diagnostic tests were each
assessed regarding contemporary surveillance for intestinal schis-
tosomiasis finding that Kato-Katz sampling is a satisfactory diag-
nostic standalone in high-transmission settings but in
low-transmission settings should be augmented or replaced by
urine-CCA dipsticks. DNA-TaqMan® appears suitable in both
endemic settings though is only implementable if resources permit.
In low-transmission settings, SEA-ELISA remains the method of
choice to evidence an absence of infection. In the dearth of a diag-
nostic ‘gold’ standard for intestinal schistosomiasis, LCA offered
useful computations of diagnostic performance between tests.
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